Clinical Trials Directory

Trials / Completed

CompletedNCT01873378

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Surgical Effects of GnRH Agonist Pretreatment on Cold Loop Hysteroscopic Myomectomy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Azienda Ospedaliera S. Maria della Misericordia · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary outcome of this study is to assess if the GnRHa administration before cold loop hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic therapy in terms of distension liquid absorption and duration of the procedures.

Conditions

Interventions

TypeNameDescription
DRUGTriptorelin 3.75 mg

Timeline

Start date
2013-01-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2013-06-10
Last updated
2015-08-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01873378. Inclusion in this directory is not an endorsement.

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy (NCT01873378) · Clinical Trials Directory